BPRN vs CHMG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BPRN exhibits weak financial health with a Piotroski F-Score of 3/9, signaling significant concerns in profitability, leverage, and operating efficiency. Despite this, the stock shows strong revenue growth (52.4% YoY) and impressive earnings surprises, with a recent YoY EPS growth of 50.8% and a staggering Q/Q EPS jump of 850%. Valuation appears reasonable relative to peers with a P/E of 14.21 vs. sector average of 21.55, and a Price/Book of 0.94 suggesting near-book value trading. However, bearish insider activity, low technical trend (10/100), and lack of key financial data (Altman Z-Score, debt/equity, cash flow) constrain confidence in sustained outperformance.
CHMG shows bullish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Key strengths include strong valuation and growth metrics.
Compare Another Pair
Related Comparisons
BPRN vs CHMG: Head-to-Head Comparison
This page compares Princeton Bancorp, Inc. (BPRN) and Chemung Financial Corporation (CHMG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.